317 related articles for article (PubMed ID: 31278949)
1. Validation, clinical utility and limitations of the Amsterdam-Oxford model for primary sclerosing cholangitis.
Goet JC; Floreani A; Verhelst X; Cazzagon N; Perini L; Lammers WJ; de Vries AC; van der Meer AJ; van Buuren HR; Hansen BE
J Hepatol; 2019 Nov; 71(5):992-999. PubMed ID: 31278949
[TBL] [Abstract][Full Text] [Related]
2. A novel prognostic model for transplant-free survival in primary sclerosing cholangitis.
de Vries EM; Wang J; Williamson KD; Leeflang MM; Boonstra K; Weersma RK; Beuers U; Chapman RW; Geskus RB; Ponsioen CY
Gut; 2018 Oct; 67(10):1864-1869. PubMed ID: 28739581
[TBL] [Abstract][Full Text] [Related]
3. Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.
de Vries EMG; Färkkilä M; Milkiewicz P; Hov JR; Eksteen B; Thorburn D; Chazouillères O; Pares A; Nygård S; Gilja OH; Wunsch E; Invernizzi P; Carbone M; Bernuzzi F; Boberg KM; Røsjø H; Rosenberg W; Beuers UH; Ponsioen CY; Karlsen TH; Vesterhus M
Liver Int; 2017 Oct; 37(10):1554-1561. PubMed ID: 28267887
[TBL] [Abstract][Full Text] [Related]
4. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
Weismüller TJ; Trivedi PJ; Bergquist A; Imam M; Lenzen H; Ponsioen CY; Holm K; Gotthardt D; Färkkilä MA; Marschall HU; Thorburn D; Weersma RK; Fevery J; Mueller T; Chazouillères O; Schulze K; Lazaridis KN; Almer S; Pereira SP; Levy C; Mason A; Naess S; Bowlus CL; Floreani A; Halilbasic E; Yimam KK; Milkiewicz P; Beuers U; Huynh DK; Pares A; Manser CN; Dalekos GN; Eksteen B; Invernizzi P; Berg CP; Kirchner GI; Sarrazin C; Zimmer V; Fabris L; Braun F; Marzioni M; Juran BD; Said K; Rupp C; Jokelainen K; Benito de Valle M; Saffioti F; Cheung A; Trauner M; Schramm C; Chapman RW; Karlsen TH; Schrumpf E; Strassburg CP; Manns MP; Lindor KD; Hirschfield GM; Hansen BE; Boberg KM;
Gastroenterology; 2017 Jun; 152(8):1975-1984.e8. PubMed ID: 28274849
[TBL] [Abstract][Full Text] [Related]
5. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of children and adolescents with primary sclerosing cholangitis and autoimmune sclerosing cholangitis.
Smolka V; Karaskova E; Tkachyk O; Aiglova K; Ehrmann J; Michalkova K; Konecny M; Volejnikova J
Hepatobiliary Pancreat Dis Int; 2016 Aug; 15(4):412-8. PubMed ID: 27498582
[TBL] [Abstract][Full Text] [Related]
7. Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study.
de Vries EM; de Krijger M; Färkkilä M; Arola J; Schirmacher P; Gotthardt D; Goeppert B; Trivedi PJ; Hirschfield GM; Ytting H; Vainer B; Buuren HR; Biermann K; Harms MH; Chazouilleres O; Wendum D; Kemgang AD; Chapman RW; Wang LM; Williamson KD; Gouw AS; Paradis V; Sempoux C; Beuers U; Hübscher SG; Verheij J; Ponsioen CY
Hepatology; 2017 Mar; 65(3):907-919. PubMed ID: 27880989
[TBL] [Abstract][Full Text] [Related]
8. Assessing the Validity of Adult-derived Prognostic Models for Primary Sclerosing Cholangitis Outcomes in Children.
Deneau MR; Valentino PL; Mack C; Alqoaer K; Amin M; Amir AZ; Aumar M; Auth M; Broderick A; DiGuglielmo M; Draijer LG; El-Matary W; Ferrari F; Furuya KN; Gottrand F; Gupta N; Homan M; Jensen MK; Kamath BM; Kim KM; Kolho KL; Koot B; Iorio R; Martinez M; Miloh T; Mohan P; Palle S; Papadopoulou A; Ricciuto A; Saubermann L; Sathya P; Shteyer E; Smolka V; Tanaka A; Varier R; Venkat V; Vitola B; Woynarowski M; Guthery S
J Pediatr Gastroenterol Nutr; 2020 Jan; 70(1):e12-e17. PubMed ID: 31651664
[TBL] [Abstract][Full Text] [Related]
9. The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.
Deneau MR; El-Matary W; Valentino PL; Abdou R; Alqoaer K; Amin M; Amir AZ; Auth M; Bazerbachi F; Broderick A; Chan A; Cotter J; Doan S; El-Youssef M; Ferrari F; Furuya KN; Gottrand M; Gottrand F; Gupta N; Homan M; Kamath BM; Kim KM; Kolho KL; Konidari A; Koot B; Iorio R; Ledder O; Mack C; Martinez M; Miloh T; Mohan P; O'Cathain N; Papadopoulou A; Ricciuto A; Saubermann L; Sathya P; Shteyer E; Smolka V; Tanaka A; Varier R; Venkat V; Vitola B; Vos MB; Woynarowski M; Yap J; Jensen MK
Hepatology; 2017 Aug; 66(2):518-527. PubMed ID: 28390159
[TBL] [Abstract][Full Text] [Related]
10. Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC-IBD patients.
Nordenvall C; Olén O; Nilsson PJ; von Seth E; Ekbom A; Bottai M; Myrelid P; Bergquist A
Aliment Pharmacol Ther; 2018 Jan; 47(2):238-245. PubMed ID: 29064110
[TBL] [Abstract][Full Text] [Related]
11. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
12. The natural history of small-duct primary sclerosing cholangitis.
Björnsson E; Olsson R; Bergquist A; Lindgren S; Braden B; Chapman RW; Boberg KM; Angulo P
Gastroenterology; 2008 Apr; 134(4):975-80. PubMed ID: 18395078
[TBL] [Abstract][Full Text] [Related]
13. Clinical analysis of liver transplantation in autoimmune liver diseases.
Zhong CP; Xi ZF; Xia Q
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):27-31. PubMed ID: 29428100
[TBL] [Abstract][Full Text] [Related]
14. Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis.
Kirstein MM; Book T; Manns MP; von Hahn T; Voigtländer T
United European Gastroenterol J; 2020 Jul; 8(6):716-724. PubMed ID: 32366182
[TBL] [Abstract][Full Text] [Related]
15. The MELD score predicts the short-term and overall survival after liver transplantation in patients with primary sclerosing cholangitis or autoimmune liver diseases.
Hoffmann K; Hinz U; Hillebrand N; Ganten T; Gotthardt D; Longerich T; Schirmacher P; Schemmer P
Langenbecks Arch Surg; 2014 Dec; 399(8):1001-9. PubMed ID: 25106131
[TBL] [Abstract][Full Text] [Related]
16. Liver Transplantation for Children With Primary Sclerosing Cholangitis and Autoimmune Hepatitis: UNOS Database Analysis.
Jossen J; Annunziato R; Kim HS; Chu J; Arnon R
J Pediatr Gastroenterol Nutr; 2017 Apr; 64(4):e83-e87. PubMed ID: 27755342
[TBL] [Abstract][Full Text] [Related]
17. Pediatric liver transplantation for primary sclerosing cholangitis.
Miloh T; Anand R; Yin W; Vos M; Kerkar N; Alonso E;
Liver Transpl; 2011 Aug; 17(8):925-33. PubMed ID: 21506253
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.
Alexander J; Lord JD; Yeh MM; Cuevas C; Bakthavatsalam R; Kowdley KV
Liver Transpl; 2008 Feb; 14(2):245-51. PubMed ID: 18236405
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of donation after circulatory death liver transplantation in primary sclerosing cholangitis.
Trivedi PJ; Scalera I; Slaney E; Laing RW; Gunson B; Hirschfield GM; Schlegel A; Ferguson J; Muiesan P
J Hepatol; 2017 Nov; 67(5):957-965. PubMed ID: 28690174
[TBL] [Abstract][Full Text] [Related]
20. Roux-en-Y choledochojejunostomy versus duct-to-duct biliary anastomosis in liver transplantation for primary sclerosing cholangitis: a meta-analysis.
Wells MM; Croome KP; Boyce E; Chandok N
Transplant Proc; 2013; 45(6):2263-71. PubMed ID: 23953538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
